AbCellera Biologics Inc.
NASDAQ:ABCL · NASDAQ Global Select
-$0.02 today
Vol 6.76M · Avg 6.37M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+66.07%
Period High
$6.46
Period Low
$2.78
Latest
$5.53
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$5.33B
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.52B
Pharvaris N.V.
NASDAQ:PHVS
$2.29B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.20B
Nuvation Bio Inc.
NYSE:NUVB
$1.86B
Immunome, Inc.
NASDAQ:IMNM
$1.73B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.69B
Biohaven Ltd.
NYSE:BHVN
$1.42B
Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
$1.21B
Janux Therapeutics, Inc.
NASDAQ:JANX
$852.56M
What is the latest ABCL filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does ABCL have?
Intrinsic Alpha currently shows 20 recent filings for ABCL.
Explore More
Continue the stock analysis
Jump to another research area for this company.